Avinash Kalsariya

Research Scientist | Microbial Fermentation |Recombinant Protein | Upstream R&D

Role: Research Scientist at Heni Innovation | Zero Cow Factory
Location: Surat, GJ, IN
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

About Avinash Kalsariya

Biotech enthusiast with 3 years of hands-on experience in microbial fermentation…

Experience

Research Scientist
Heni Innovation | Zero Cow Factory
Apr 2025 — Present · Surat, IN

Education

Institute of Advanced Research, Gandhinagar
M.Sc.
2020 — 2022
Uka Tarsadia University
B.Sc.
2017 — 2020

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@heniinnovation.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Heni Innovation | Zero Cow Factory

Biotechnology · 16 employees · Founded 2020 · Surat, India

Heni Innovation is India’s first company harnessing precision fermentation technology to create complex recombinant molecules for both food and pharma. From pioneering animal free A2 milk proteins through our flagship brand Zero Cow Factory (ZCF) to breakthroughs in GLP 1 therapeutics, therapeutics, we are reshaping industries with sustainable, scalable innovation. Our expertise spans the full development pipeline — strain engineering, fermentation, and downstream processing — backed by 11 patents across India and the United States. Our Journey of Innovations: From Dairy Proteins to Pharma Breakthroughs — Precision Fermentation by Heni Innovation. Zero Cow Factory (ZCF): Reinventing Dairy Through our flagship brand Zero Cow Factory, we are redefining the dairy industry by producing India’s first animal-free milk protein — and the world’s first A2 milk protein (Casein) via precision fermentation that is ethical, safe, delicious, and identical to cow’s milk without involving animals. Pharma Breakthroughs: P-29 Semaglutide Building on this foundation, we are expanding into pharmaceuticals with innovations like P-29 Semaglutide enabling to secure cost effective, reliable and sustainable supply chain. Expanding the Horizons… GLP 1 and Protein-Based Therapeutics Projected to reach $100Bn by 2030, GLP 1 demand underscores the need for scalable, cost effective, and sustainable supply chains — which our precision fermentation platform delivers with unmatched efficiency.

heniinnovation.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Avinash Kalsariya

Experience

Research Scientist

Education

Institute of Advanced Research, Gandhinagar

Uka Tarsadia University

Find verified contacts for anyone on LinkedIn